AKT1 and colorectal cancer: Two main downstream pathways that harbor mutations in over 50% of colorectal cancers are mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR pathways [4, 5].